LAM
MD icon

Lebenthal Asset Management’s Pediatrix Medical MD Stock Holding History

Lebenthal Asset Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,386
Closed -$492K – 332
2016
Q4 		$492K Sell
7,386
-14,004
-65% -$911K 0.06% 254
2016
Q3 		$1.42M Sell
21,390
-621
-3% -$42.5K 0.18% 169
2016
Q2 		$1.59M Buy
+22,011
New +$1.51M 0.21% 154

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Lebenthal Asset Management's MD Position: Q1 2017 in Review

Lebenthal Asset Management sold out of Pediatrix Medical (MD) in Q1 2017, closing a stake of 7,386 shares — an estimated $492K sold.

Lebenthal Asset Management first reported a position in MD in Q2 2016 and held it in 3 quarters. The position peaked at $1.59M in Q2 2016. 359 funds tracked by Wall St. Rank hold MD as of Q1 2017.

  • Lebenthal Asset Management reported no remaining Pediatrix Medical position as of Q1 2017 after selling out during the quarter.
  • Lebenthal Asset Management sold 7,386 Pediatrix Medical shares in Q1 2017, an estimated $492K.
  • Lebenthal Asset Management first reported a position in Pediatrix Medical in Q2 2016 and held it in 3 quarters.
  • Lebenthal Asset Management's Pediatrix Medical position peaked at $1.59M in Q2 2016.
  • 359 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2017.

Based on Lebenthal Asset Management's 13F filing for Q1 2017, filed 15 May 2017.